Aptose生物科學 APTO 深 滬
等待開盤 08-26 09:30:00 美东时间
1.71
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.71
- 總市值 436.46万
- 52周最高 42.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.35
- 委 比 0.00%
- 總股本 255.24万
- 歷史最高 5032.80
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.30
- 每 手 1
- 風險率 3.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aptose Biosciences Secures Funding for Drug Development
Aptose Biosciences ( ($TSE:APS) ) has issued an update. On August 22, 2025, Apt...
今天 05:31
Aptose Biosciences Appoints New Independent Auditor
The latest announcement is out from Aptose Biosciences ( ($TSE:APS) ). On Augus...
08-23 05:30
Aptose Biosciences Secures $2M Advance for AML Therapy
The latest announcement is out from Aptose Biosciences ( ($TSE:APS) ). On July ...
07-16 05:30
Delisting of Securities from The Nasdaq Stock Market
The Nasdaq Stock Market announced on July 11, 2025, that it will delist the securities of multiple companies, including NKGen Biotech, Inc., Aquaron Acquisition Corp., Bannix Acquisition Corp., Avenue Therapeutics, Inc., WinVest Acquisition Corp., IMAC Holdings, Inc., Lytus Technologies Holdings PTV Ltd., Luokung Technology Corp., Aptose Biosciences, Inc., Virpax Pharmaceuticals, Inc., Phoenix Motor Inc., Denali Capital Acquisition Corp., Thunder...
07-11 20:05
Aptose Biosciences Upgrades to OTCQB Market Listing
An update from Aptose Biosciences ( ($TSE:APS) ) is now available. Aptose Biosc...
07-01 20:37
Aptose Biosciences Secures $8.5M Loan for AML Therapy
Aptose Biosciences ( ($TSE:APS) ) just unveiled an update. On June 20, 2025, Ap...
06-20 20:28
Aptose Biosciences Begins 120 mg Dosing in TUSCANY Trial
Aptose Biosciences ( ($TSE:APS) ) has issued an announcement. On May 20, 2025, ...
05-20 19:59
Aptose’s TUSCANY Trial Data to be Presented at EHA 2025
Aptose Biosciences ( ($TSE:APS) ) has issued an announcement. Aptose Bioscience...
05-15 01:38
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
Aptose Biosciences ( ($TSE:APS) ) has shared an announcement. Aptose Bioscience...
05-08 19:57
Aptose common shares to delist from Nasdaq
Aptose Biosciences (NASDAQ:APTO) announced that Nasdaq has determined to delist the common shares of the company, as of April 2, 2025. Under the terms of the Nasdaq’s decision in this matter, the comp...
04-01 20:46
